This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brachman, D. G. Articles by Weichselbaum, R. R. Search for Related Content PubMed PubMed Citation Articles by Brachman, D. G. Articles by Weichselbaum, R. R.

p53 Mutation Does Not Correlate with Radiosensitivity in 24 Head and Neck Cancer Cell Lines¹

Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637

The molecular basis of tumor response to therapeutic radiation is poorly understood. Recent evidence suggests the p53 tumor suppressor gene may be involved in production of the G₁ arrest seen following DNA damage by X-irradiation. It has further been proposed that tumor cells lacking the p53 checkpoint function are likely to be more sensitive to cell killing by X-irradiation because these cells enter S phase despite unrepaired DNA damage. We tested the hypothesis that tumor cells with p53 mutations are more radiosensitive by correlating the in vitro surviving fraction at 2 Gy with the mutational status of 24 head and neck squamous cell cancer cell lines. p53 mutations were present in 15 of 24 (63%) of tumors; all were homozygous changes occurring within exons 5–9. The surviving fraction at 2 Gy for the group with mutations was 0.568 compared to 0.507 for tumors without mutations (P = 0.28, Mann-Whitney test). Furthermore, no association between radiosensitivity and mutational type, codon location, or predicted amino acid alteration was noted. Our data do not support the hypothesis that p53 gene alteration predisposes tumor cells to increased cell killing via radiation.

¹ This work was supported by NIH Grant CA 41068, The Chicago Tumor Institute, and the Center for Radiation Therapy.

² To whom requests for reprints should be addressed.

Received 5/10/93. Accepted 7/ 6/93.

This article has been cited by other articles:

				D. Ronchetti, C. B. Neglia, B. M. Cesana, N. Carboni, A. Neri, G. Pruneri, and L. Pignataro Association Between p53 Gene Mutations and Tobacco and Alcohol Exposure in Laryngeal Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 303 - 306. [Abstract] [Full Text] [PDF]

				M. L. Fishel, S. M. Delaney, L. D. Friesen, R. J. Hansen, E. G. Zuhowski, R. C. Moschel, M. J. Egorin, and M. E. Dolan Enhancement of Platinum-induced Cytotoxicity by O6-Benzylguanine Mol. Cancer Ther., July 1, 2003; 2(7): 633 - 640. [Abstract] [Full Text] [PDF]

				W. Eicheler, D. Zips, A. Dorfler, R. Grenman, and M. Baumann Splicing Mutations in TP53 in Human Squamous Cell Carcinoma Lines Influence Immunohistochemical Detection J. Histochem. Cytochem., February 1, 2002; 50(2): 197 - 204. [Abstract] [Full Text] [PDF]

				I. M. Hussaini, J. E. Carpenter, G. T. Redpath, J. J. Sando, M. E. Shaffrey, and S. R. VandenBerg Protein kinase C-{eta} regulates resistance to UV- and {gamma}-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation Neuro-oncol, January 1, 2002; 4(1): 9 - 21. [Abstract] [PDF]

				A. Matsuyama, H. Inoue, K. Shibuta, Y. Tanaka, G. F. Barnard, K. Sugimachi, and M. Mori Hepatoma-derived Growth Factor Is Associated with Reduced Sensitivity to Irradiation in Esophageal Cancer Cancer Res., August 1, 2001; 61(15): 5714 - 5717. [Abstract] [Full Text] [PDF]

				R. C. Zellars, S. G. Hilsenbeck, G. M. Clark, D. C. Allred, T. S. Herman, G. C. Chamness, and R. M. Elledge Prognostic Value of p53 for Local Failure in Mastectomy-Treated Breast Cancer Patients J. Clin. Oncol., May 9, 2000; 18(9): 1906 - 1913. [Abstract] [Full Text] [PDF]

				S. J. Chmura, M. E. Dolan, A. Cha, H. J. Mauceri, D. W. Kufe, and R. R. Weichselbaum In Vitro and in Vivo Activity of Protein Kinase C Inhibitor Chelerythrine Chloride Induces Tumor Cell Toxicity and Growth Delay in Vivo Clin. Cancer Res., February 1, 2000; 6(2): 737 - 742. [Abstract] [Full Text]

				Y. Xie, J. D. Gilbert, J. H. Kim, and S. O. Freytag Efficacy of Adenovirus-mediated CD/5-FC and HSV-1 Thymidine Kinase/Ganciclovir Suicide Gene Therapies Concomitant with p53 Gene Therapy Clin. Cancer Res., December 1, 1999; 5(12): 4224 - 4232. [Abstract] [Full Text] [PDF]

				W. K. Dahlberg, E. I. Azzam, Y. Yu, and J. B. Little Response of Human Tumor Cells of Varying Radiosensitivity and Radiocurability to Fractionated Irradiation Cancer Res., October 1, 1999; 59(20): 5365 - 5369. [Abstract] [Full Text] [PDF]

				S. J. Advani, S.-M. Chung, S. Y. Yan, G. Y. Gillespie, J. M. Markert, R. J. Whitley, B. Roizman, and R. R. Weichselbaum Replication-competent, Nonneuroinvasive Genetically Engineered Herpes Virus Is Highly Effective in the Treatment of Therapy-resistant Experimental Human Tumors Cancer Res., May 1, 1999; 59(9): 2055 - 2058. [Abstract] [Full Text] [PDF]

				J. M. Brown and B. G. Wouters Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents Cancer Res., April 1, 1999; 59(7): 1391 - 1399. [Abstract] [Full Text] [PDF]

				G. S. Hagopian, G. B. Mills, A. R. Khokhar, R. C. Bast Jr., and Z. H. Siddik Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV) Clin. Cancer Res., March 1, 1999; 5(3): 655 - 663. [Abstract] [Full Text] [PDF]

				U.M. Moll and L.M. Schramm p53--An Acrobat in Tumorigenesis Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(1): 23 - 37. [Abstract] [Full Text] [PDF]

				N. S. Pellegata, R. J. Antoniono, J. L. Redpath, and E. J. Stanbridge DNA damage and p53-mediated cell cycle arrest: A reevaluation PNAS, December 24, 1996; 93(26): 15209 - 15214. [Abstract] [Full Text] [PDF]

				M. F. Spafford, J. Koeppe, Z. Pan, P. G. Archer, A. D. Meyers, and W. A. Franklin Correlation of Tumor Markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 With Survival and Metastasis in Laryngeal Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, June 1, 1996; 122(6): 627 - 632. [Abstract] [PDF]

				R. D. Ennis, J. P.S. Knisely, L. D. Wilson, K. Pantel, H. Gath, E. Heissler, G. D. Kao, M. Rudoltz, S. Denic, J. A. Brennan, et al. Staging of Head and Neck Cancer N. Engl. J. Med., June 29, 1995; 332(26): 1787 - 1790. [Full Text]